Russia’s Defense Minister suggested he wants to clone a group of ancient warriors.
That’s going to be tricky. To date, there haven’t been any human clones, and the odds are low for even non-human clones.
The legality of cloning is murky because of the medical uses for specific kinds of cloning.
When you hold a job like Defense Minister of Russia, you presumably have to be bold and think outside the box to protect your country from enemy advances. And with his latest strategic idea cloning an entire army of ancient warriors Sergei Shoigu is certainly taking a big swing.
Close
An early clinical trial recently showed that the new Moderna COVID-19 booster could be an effective shield against the variants of coronavirus originally found in South Africa and Brazil.
According to ScienceAlert, the American biotech company began to develop variant-specific boosters earlier this year after evidence that several variants of COVID-19 can break through present vaccines.
This is Moderna s pioneering clinical trial in humans, following early trials on mice, and so far, the results are found promising.
Stephen Bancel, Moderna CEO said in a press release the company posted on its website, they are encouraged by this new date, which strengthens their confidence that their booster scheme should be protective against the said newly-identified variants.
Diagnostics Advancement along with several R&D investments Drives the Genomics Market | UnivDatos Market Insights
NOIDA, India, May 5, 2021 /PRNewswire/ A comprehensive overview of the genomics market is recently added by UnivDatos Market Insights to its humongous database. The genomics market report has been aggregated by collecting informative data of various dynamics such as market drivers, restraints, and opportunities. This innovative report makes use of several analyses to get a closer outlook on the genomics market. The genomics market report offers a detailed analysis of the latest industry developments and trending factors in the market that are influencing the market growth. Furthermore, this statistical market research repository examines and estimates the genomics market at the global and regional levels.
Black and Latinx Surgeons Continue to Hit Glass Ceiling in America
05/05/2021 | 11:00am EDT
Send by mail :
Message :
Required fields
Richmond, VA, May 05, 2021 (GLOBE NEWSWIRE) Among the upper echelons of academic surgery, Black and Latinx representation has remained flat over the past six years, according to a study published today in JAMA Surgery by researchers at Virginia Commonwealth University Massey Cancer Center and University of Florida Health.
The study tracked trends across more than 15,000 faculty in surgery departments across the U.S. between 2013-2019. Although the data revealed modest diversity gains among early-career faculty during this period, especially for Black and Latina women, the percentage of full professors and department chairs identifying as Black or Latinx continued to hover in the single digits.